-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Aleafia Health Q1 2023 Revenue Grows 41% YoY, What About Profit?
Aleafia Health Q1 2023 Revenue Grows 41% YoY, What About Profit?
Aleafia Health Inc. (OTCQX:ALEAF) (TSX:AH) revenue in Q1 2023 was $16.5 million, a 41% increase compared to $11.65 million in Q1 2022.
Q1 2023 Financial Highlights
-
Total gross profit 22%, compared to 43% in Q1 2022.
-
Adjusted EBITDA was a loss of $938,000, compared to loss of $3.43 million in Q1 2022.
-
Net profit was a loss of $4.47 million, an unfavorable decrease of 185% compared to net profit of $5.23 million in Q1 2022.
Branded cannabis net revenue, quarter over quarter, increased 25%: Aleafia Health continued its upward sales growth trend, with branded cannabis net revenue increasing 24% to a record $10.0 million from $8.0 million quarter over quarter. In the key branded adult-use market, the company's net revenue increased 107% to $6.7 million from $3.2 million in the same period last year.
"Our pivot to a branded cannabis strategy is the success story driving the three pillars of company revenue: adult-use branded cannabis, a 'sticky' recurring medical cannabis revenue stream and growing higher margin international sales," stated Aleafia Health CEO Tricia Symmes. "As a result of revenue increases, the company has achieved the 2nd highest growth rate amongst top 12 Canadian LPs in retail sell through over the prior quarter while achieving a #12 ranking for market share in our core markets for Q2 CY2022."
"We are striving to achieve breakeven adjusted EBITDA profitability by the end of FY2023," Sale said. "Firstly, we are increasing revenue by capturing market share. SKU optimization has furthered revenue growth, which aligns the portfolio with the highest selling product formats with strongest margins, coupled with moderate and strategic price increases. Second, we are relentlessly focused on cost rationalization. In addition to difficult headcount reductions and other initiatives, the company has engaged in vendor consolidation to reduce complexity across sites while negotiating trusted vendor price improvements due to economies of scale. With all of these efforts combined, the company has extracted $20 million in annualized SG&A savings over the last four quarters, and break-even adjusted EBITDA profitability is within our grasp during FY2023, a milestone for the company."
Photo: Benzinga; Sources: courtesy of Kindel Media via Pexels
Related News
Benzinga CEO Predicts $1B In Cannabis Deals Closing In Just 2 Days In September: Find Out Where And How!
Aleafia Health Hits Record $43.1M Net Revenue In 2022 15-Month Fiscal Year, Closes Debenture Amendment Transaction
Aleafia Health Reaffirms Revenue Guidance, Implements $6.7 Million In Annualized Cost Savings
Aleafia Health Inc. (OTCQX:ALEAF) (TSX:AH) revenue in Q1 2023 was $16.5 million, a 41% increase compared to $11.65 million in Q1 2022.
Aleafia Health Inc.(多倫多證券交易所:ALEAF)(多倫多證券交易所:AH)收入2023年第一季度1650萬美元,增長了41%相比之下,2022年第一季度為1165萬美元。
Q1 2023 Financial Highlights
2023年第一季度財務亮點
-
Total gross profit 22%, compared to 43% in Q1 2022.
-
Adjusted EBITDA was a loss of $938,000, compared to loss of $3.43 million in Q1 2022.
-
Net profit was a loss of $4.47 million, an unfavorable decrease of 185% compared to net profit of $5.23 million in Q1 2022.
-
毛利潤總額22%,而2022年第一季度這一比例為43%。
-
調整後的EBITDA為虧損93.8萬美元,相比之下,2022年第一季度虧損343萬美元。
-
淨利潤虧損447萬美元,不利的降幅為185%相比之下,2022年第一季度的淨利潤為523萬美元。
Branded cannabis net revenue, quarter over quarter, increased 25%: Aleafia Health continued its upward sales growth trend, with branded cannabis net revenue increasing 24% to a record $10.0 million from $8.0 million quarter over quarter. In the key branded adult-use market, the company's net revenue increased 107% to $6.7 million from $3.2 million in the same period last year.
品牌大麻淨收入,季度環比增長25%:Aleafia Health繼續保持銷售增長的趨勢,品牌大麻的淨收入從本季度的800萬美元增長了24%,達到創紀錄的1000萬美元。在關鍵的成人品牌市場,該公司的淨收入從去年同期的320萬美元增長到670萬美元,增幅為107%。
"Our pivot to a branded cannabis strategy is the success story driving the three pillars of company revenue: adult-use branded cannabis, a 'sticky' recurring medical cannabis revenue stream and growing higher margin international sales," stated Aleafia Health CEO Tricia Symmes. "As a result of revenue increases, the company has achieved the 2nd highest growth rate amongst top 12 Canadian LPs in retail sell through over the prior quarter while achieving a #12 ranking for market share in our core markets for Q2 CY2022."
Aleafia Health首席執行官表示:“我們轉向品牌大麻戰略是推動公司收入三大支柱的成功故事:成人使用的品牌大麻,‘粘性’的經常性醫用大麻收入流,以及不斷增長的更高利潤率的國際銷售。”特里西亞·塞梅斯。由於收入增加,該公司在加拿大零售額排名前12位的有限合夥人中實現了比上一季度第二高的增長率,同時在2022財年第二季度我們的核心市場市場份額排名第12位。
"We are striving to achieve breakeven adjusted EBITDA profitability by the end of FY2023," Sale said. "Firstly, we are increasing revenue by capturing market share. SKU optimization has furthered revenue growth, which aligns the portfolio with the highest selling product formats with strongest margins, coupled with moderate and strategic price increases. Second, we are relentlessly focused on cost rationalization. In addition to difficult headcount reductions and other initiatives, the company has engaged in vendor consolidation to reduce complexity across sites while negotiating trusted vendor price improvements due to economies of scale. With all of these efforts combined, the company has extracted $20 million in annualized SG&A savings over the last four quarters, and break-even adjusted EBITDA profitability is within our grasp during FY2023, a milestone for the company."
Sale表示:“我們正在努力在2023財年末實現盈虧平衡調整後的EBITDA盈利能力。”首先,我們正在通過奪取市場份額來增加收入。SKU優化進一步促進了收入增長,使產品組合與最暢銷、利潤率最高的產品格式保持一致,再加上適度和戰略性的價格上漲。其次,我們堅持不懈地致力於成本合理化。除了艱難的裁員和其他舉措外,該公司還參與了供應商整合,以降低跨地點的複雜性,同時談判由於規模經濟而提高值得信賴的供應商的價格。所有這些努力加在一起,該公司在過去四個季度的年化SG&A節省了2000萬美元,在公司里程碑式的2023財年,盈虧平衡調整後的EBITDA盈利能力在我們掌握之中。
Photo: Benzinga; Sources: courtesy of Kindel Media via Pexels
圖片來源:Pexels提供的Kindel Media
Related News
相關新聞
Benzinga CEO Predicts $1B In Cannabis Deals Closing In Just 2 Days In September: Find Out Where And How!
Benzinga首席執行官預測,9月份僅兩天內就會有10億美元的大麻交易完成:找出地點和方式!
Aleafia Health Hits Record $43.1M Net Revenue In 2022 15-Month Fiscal Year, Closes Debenture Amendment Transaction
Aleafia Health在2022財年15個月淨收入達到創紀錄的4310萬美元,完成債券修正案交易
Aleafia Health Reaffirms Revenue Guidance, Implements $6.7 Million In Annualized Cost Savings
Aleafia Health重申收入指引,實施670萬美元的年化成本節約
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧